Fibrobiologics, Common Stock Stock Analysis
| FBLG Stock | 1.07 0.06 5.31% |
FibroBiologics, Common Stock is undervalued with Real Value of 3.98 and Target Price of 12.75. The main objective of FibroBiologics, Common stock analysis is to determine its intrinsic value, which is an estimate of what FibroBiologics, Common Stock is worth, separate from its market price. There are two main types of FibroBiologics, Common's stock analysis: fundamental analysis and technical analysis.
The FibroBiologics, Common stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and FibroBiologics, Common's ongoing operational relationships across important fundamental and technical indicators.
FibroBiologics, |
FibroBiologics, Stock Analysis Notes
About 23.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.55. FibroBiologics, Common had not issued any dividends in recent years. To learn more about FibroBiologics, Common Stock call the company at 281 651 5150 or check out https://www.fibrobiologics.com.FibroBiologics, Common Investment Alerts
| FibroBiologics, Common generated a negative expected return over the last 90 days | |
| FibroBiologics, Common has high historical volatility and very poor performance | |
| FibroBiologics, Common has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (16.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| FibroBiologics, Common generates negative cash flow from operations | |
| FibroBiologics, Common has a poor financial position based on the latest SEC disclosures | |
| About 23.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: FBLG Analyst Day Provides In-Depth Overview of Pipeline |
FibroBiologics, Largest EPS Surprises
Earnings surprises can significantly impact FibroBiologics, Common's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-07 | 2024-06-30 | -0.09 | -0.02 | 0.07 | 77 | ||
2024-11-27 | 2024-09-30 | -0.0867 | -0.01 | 0.0767 | 88 |
FibroBiologics, Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 38.23 M.FibroBiologics, Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.26) | (1.32) | |
| Return On Capital Employed | (3.88) | (3.68) | |
| Return On Assets | (1.26) | (1.32) | |
| Return On Equity | (15.13) | (14.37) |
Management Efficiency
FibroBiologics, Common has return on total asset (ROA) of (0.6577) % which means that it has lost $0.6577 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.6786) %, meaning that it created substantial loss on money invested by shareholders. FibroBiologics, Common's management efficiency ratios could be used to measure how well FibroBiologics, Common manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.32. The FibroBiologics, Common's current Return On Capital Employed is estimated to increase to -3.68. At this time, FibroBiologics, Common's Total Assets are most likely to increase significantly in the upcoming years. The FibroBiologics, Common's current Total Current Assets is estimated to increase to about 11.1 M, while Non Current Assets Total are projected to decrease to roughly 1.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.03 | 0.04 | |
| Tangible Book Value Per Share | 0.03 | 0.04 | |
| Enterprise Value Over EBITDA | (53.10) | (55.75) | |
| Price Book Value Ratio | 679.14 | 713.10 | |
| Enterprise Value Multiple | (53.10) | (55.75) | |
| Price Fair Value | 679.14 | 713.10 | |
| Enterprise Value | 1.1 B | 1 B |
The decision-making processes within FibroBiologics, Common are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Technical Drivers
As of the 26th of February, FibroBiologics, Common shows the Standard Deviation of 6.61, coefficient of variation of (600.15), and Mean Deviation of 5.08. FibroBiologics, Common technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm FibroBiologics, Common standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if FibroBiologics, Common is priced favorably, providing market reflects its regular price of 1.07 per share. Given that FibroBiologics, Common is a hitting penny stock territory we advise to closely look at its jensen alpha.FibroBiologics, Common Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. FibroBiologics, Common middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for FibroBiologics, Common. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
FibroBiologics, Common Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific FibroBiologics, Common insiders, such as employees or executives, is commonly permitted as long as it does not rely on FibroBiologics, Common's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases FibroBiologics, Common insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ruben Garcia over two months ago Acquisition by Ruben Garcia of 176200 shares of FibroBiologics, Common at 2.36 subject to Rule 16b-3 | ||
O'heeron Pete over two months ago Disposition of 100000 shares by Oheeron Pete of FibroBiologics, Common subject to Rule 16b-3 | ||
O'heeron Pete over two months ago Disposition of 50000 shares by Oheeron Pete of FibroBiologics, Common subject to Rule 16b-3 | ||
Niklas Victoria Ninon Olivia over a year ago FibroBiologics Common exotic insider transaction detected | ||
Cilento Richard C Jr over a year ago FibroBiologics Common exotic insider transaction detected |
FibroBiologics, Common Outstanding Bonds
FibroBiologics, Common issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. FibroBiologics, Common uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most FibroBiologics, bonds can be classified according to their maturity, which is the date when FibroBiologics, Common Stock has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
FibroBiologics, Common Predictive Daily Indicators
FibroBiologics, Common intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of FibroBiologics, Common stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
FibroBiologics, Common Forecast Models
FibroBiologics, Common's time-series forecasting models are one of many FibroBiologics, Common's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary FibroBiologics, Common's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About FibroBiologics, Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how FibroBiologics, Common prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling FibroBiologics, shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as FibroBiologics, Common. By using and applying FibroBiologics, Stock analysis, traders can create a robust methodology for identifying FibroBiologics, entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Current FibroBiologics, Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. FibroBiologics, analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. FibroBiologics, analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 12.75 | Strong Buy | 3 | Odds |
Most FibroBiologics, analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand FibroBiologics, stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of FibroBiologics, Common, talking to its executives and customers, or listening to FibroBiologics, conference calls.
FibroBiologics, Stock Analysis Indicators
FibroBiologics, Common Stock stock analysis indicators help investors evaluate how FibroBiologics, Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading FibroBiologics, Common shares will generate the highest return on investment. By understating and applying FibroBiologics, Common stock analysis, traders can identify FibroBiologics, Common position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 2.3 M | |
| Common Stock Shares Outstanding | 28.2 M | |
| Total Stockholder Equity | 1.3 M | |
| Property Plant And Equipment Net | 2.6 M | |
| Cash And Short Term Investments | 9.2 M | |
| Cash | 9.2 M | |
| Accounts Payable | 1.4 M | |
| Net Debt | -7.4 M | |
| 50 Day M A | 1.8339 | |
| Total Current Liabilities | 9.2 M | |
| Other Operating Expenses | 8.9 M | |
| Non Current Assets Total | 2.6 M | |
| Stock Based Compensation | 1.8 M |
Complementary Tools for FibroBiologics, Stock analysis
When running FibroBiologics, Common's price analysis, check to measure FibroBiologics, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroBiologics, Common is operating at the current time. Most of FibroBiologics, Common's value examination focuses on studying past and present price action to predict the probability of FibroBiologics, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroBiologics, Common's price. Additionally, you may evaluate how the addition of FibroBiologics, Common to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance |